IKZF2 Drives Self-Renewal and Blocks Myeloid Differentiation Programs in Myeloid Leukemic Stem Cells
Park, Sun-Mi, Cho, Hyunwoo, Thornton, Angela, Barlowe, Trevor Stephen, Chou, Timothy, Chhangawala, Sagar, Fairchild, Lauren, Chow, Arthur, Taggart, James, Schurer, Alexander, Gruet, Antoine, Witkin, Matthew, Kim, Jun Hyun, Shevach, Ethan, Krivstov, Andrei, Armstrong, Scott A., Leslie, Christina, Kharas, Michael G.
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Final Report of Phase 1 Study of the DOT1L Inhibitor, Pinometostat (EPZ-5676), in Children with Relapsed or Refractory MLL-r Acute Leukemia
Shukla, Neerav, Wetmore, Cynthia, O'Brien, Maureen M, Silverman, Lewis B., Brown, Patrick, Cooper, Todd M, Thomson, Blythe, Blakemore, Stephen J., Daigle, Scott, Suttle, Ben, Waters, Nigel J., Krivstov, Andrei V, Armstrong, Scott A., Ho, Peter T, Gore, Lia
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Preliminary Report of the Phase 1 Study of the DOT1L Inhibitor, Pinometostat, EPZ-5676, in Children with Relapsed or Refractory MLL-r Acute Leukemia: Safety, Exposure and Target Inhibition
Shukla, Neerav, O'Brien, Maureen M., Silverman, Lewis B., Pauly, Melinda, Wetmore, Cynthia, Loh, Mignon L., Whitlock, James A., Brown, Patrick, Thomson, Blythe, Blakemore, Stephen J., Daigle, Scott, Pimentel, Patricia, Waters, Nigel J., Krivstov, Andrei V, Koche, Richard, Armstrong, Scott A., Ho, Peter T, Gore, Lia
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
A Phase 1 Study of the DOT1L Inhibitor, Pinometostat (EPZ-5676), in Adults with Relapsed or Refractory Leukemia: Safety, Clinical Activity, Exposure and Target Inhibition
Stein, Eytan M., Garcia-Manero, Guillermo, Rizzieri, David A., Tibes, Raoul, Berdeja, Jesus G., Jongen-Lavrencic, Mojca, Altman, Jessica K., Dohner, Hartmut, Thomson, Blythe, Blakemore, Stephen J., Daigle, Scott, Fine, Greg, Waters, Nigel J., Krivstov, Andrei V, Koche, Richard, Armstrong, Scott A., Ho, Peter T, Lowenberg, Bob, Tallman, Martin S
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
The Myocyte Enhancer Factor 2C (MEF2C) Is a Direct Transcriptional Target of HOXA9 and Mediates Leukemia Survival in Human Mixed-Lineage Leukemias
Faber, Jorg, Krivstov, Andrei V., Stubbs, Matthew C., van den Heuvel-Eibrink, Marry, Kung, Andrew L., Zwaan, Christian M., Armstrong, Scott A.
Published in Blood (16.11.2007)
Published in Blood (16.11.2007)
Get full text
Journal Article